, Tracking Stock Market Picks
Enter Symbol:
Rating: THLDD
Buy $12

THRESHOLD PHARMACEUT (NASDAQ: THLD) rated to Buy with price target $12 by HC Wainwright

Friday,  Sep 5, 2014  8:25 AM ET by Dave Ficere

HC Wainwright rated THRESHOLD
PHARMACEUT (NASDAQ: THLD) to Buy with price target $12.

Threshold is focused on the discovery, development, and commercialization of small molecule therapeutics based on `Metabolic Targeting.` This approach targets abnormal glucose metabolism - a fundamental property of most solid tumors and other diseases. The company's initial focus is the treatment of cancer and benign prostatic hyperplasia, a disease characterized by overgrowth of the prostate.

HC Wainwright

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy